Published in Curr Opin Organ Transplant on April 01, 2016
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Int J Nanomedicine (2017) 0.78
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol (2016) 0.75
Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol (2017) 0.75
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med (2010) 13.33
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med (2010) 7.12
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet (2014) 6.84
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 3.57
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology (2004) 2.98
Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. J Hepatol (2014) 2.84
A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology (2010) 2.67
Nonalcoholic fatty liver disease: a systematic review. JAMA (2015) 2.58
Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology (2012) 2.44
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis (2013) 1.84
Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol (2009) 1.83
Cirrhotic cardiomyopathy. J Hepatol (2010) 1.80
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology (2014) 1.74
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol (2008) 1.71
De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl (2007) 1.68
Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl (2011) 1.58
Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk. Liver Transpl (2015) 1.47
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl (2001) 1.45
Liver transplantation at the extremes of the body mass index. Liver Transpl (2009) 1.29
The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant (2008) 1.22
Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl (2012) 1.19
Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant (2012) 1.12
Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl (2008) 1.11
Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One (2013) 1.11
Outcome after liver transplantation for NASH cirrhosis. Am J Transplant (2009) 1.07
Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl (2012) 1.03
Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology (2012) 1.03
Prediction of cardiac complications after liver transplantation. Transplantation (2009) 1.00
The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation (2002) 0.98
Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation (2009) 0.95
Prevalence and clinical associations of posttransplant fatty liver disease. Liver Int (2007) 0.95
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl (2013) 0.93
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation (2000) 0.91
Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc (2005) 0.89
Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc (2012) 0.89
Impact of body mass index on graft failure and overall survival following liver transplant. Clin Transplant (2004) 0.87
Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation. Liver Transpl (2012) 0.86
Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery. Obes Surg (2015) 0.84
Sleeve gastrectomy as treatment for severe obesity after orthotopic liver transplantation. Obes Surg (2007) 0.83
Living donor liver transplantation for non-alcoholic steatohepatitis: A single center experience. Hepatol Res (2013) 0.81
Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl (2010) 0.80
Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. Trends Mol Med (2015) 0.79
Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation. Transplant Proc (2015) 0.78
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Metabolism (2015) 0.77
Results of liver transplantation in diabetic recipients. Surgery (1993) 0.77
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation. Arq Gastroenterol (2002) 0.77
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 3.57
Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl (2007) 1.76
Autoimmune hepatitis: a review of current diagnosis and treatment. Hepat Res Treat (2011) 1.24
The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation (2012) 1.08
Burden of de novo malignancy in the liver transplant recipient. Liver Transpl (2012) 1.07
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience. Can J Gastroenterol (2008) 0.93
Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc (2012) 0.86
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review. Liver Transpl (2013) 0.83
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82
Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation. Liver Transpl (2012) 0.82
Nonalcoholic steatohepatitis in bariatric patients with a diagnosis of obstructive sleep apnea. Obes Facts (2012) 0.81
The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int (2013) 0.80
The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know. Transplantation (2016) 0.78
Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States. J Clin Gastroenterol (2017) 0.75